{
    "nct_id": "NCT02905578",
    "official_title": "A Phase II Trial of Pharmacological Ascorbate, Gemcitabine, and Nab-Paclitaxel for Metastatic Pancreatic Cancer (PACMAN 2.1)",
    "inclusion_criteria": "* Pathologic diagnosis (cell samples, biopsy, brushing, surgical sample) of adenocarcinoma of the pancreas. Cancer from the Ampullae of Vater is also eligible. The tissue sample can be from a metastatic location, like a lymph node.\n* Metastatic or node positive disease\n* One cancer site, that did not receive radiation therapy, that is at least 1 cm in size when looking at it by CT scan (CAT scan)\n* Recommended to receive gemcitabine and nab-paclitaxel\n* Failed initial therapy or be ineligible for definitive curative therapy (e.g., surgical excision, radiation therapy)\n* A platelet count of at least 100,000 cells per mL\n* A creatinine level of less than 1 1/2 times the upper limit of normal for the local lab test, or, a creatinine clearance of at least 60 mL/(min*1.73m2)\n* Not pregnant\n* Commit to using birth control during the study (all participants)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior chemotherapy to treat the metastatic disease\n* Other therapy (including radiation) within the past 4 weeks\n* Side effects from prior therapies that are still deemed moderate to severe by a physician\n* Glucose-6-phosphate dehydrogenase (G6PD) deficiency\n* Patients actively receiving insulin or who are currently recommended to receive insulin by a doctor\n* Patients requiring daily finger-stick blood glucose measurements\n* Patients who are on the following drugs and cannot have a substitution (or who decline the substitution):\n\n  * warfarin\n  * flecainide\n  * methadone\n  * amphetamines\n  * quinidine\n  * chlorpropamide\n* An active cancer, other than the pancreatic cancer, that requires treatment.\n* Enrolled in another therapeutic clinical trial\n* Uncontrolled, intercurrent illness\n* HIV positive individuals undergoing therapy due to known drug:drug interaction between antiretroviral drugs and high-dose ascorbate therapy\n* Women who are nursing",
    "miscellaneous_criteria": ""
}